500 patients67,039 observations150 daysLIVE

Patient P-03177

Synthetic patientONX-7 · Day 123 · 35–44 · M · baseline S01Open companion preview
Therapy response
Unstable
Tolerance
Deteriorating
GI state
Stable
Inflammatory state
Deteriorating
Nutritional resilience
Stable
Discontinuation risk
31%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 ONX-7 startedBaseline state S01
  2. Day 21 Trajectory diverged from predictionObserved response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 21.

Primary contributors, last 14 days
  • Toxicity+10
  • Inflammatory activity+4
  • Treatment adherence-4
  • GI instability+3
  • Nutritional resilience+3

What helped?

No interventions yet.

    LIFE OS recommendation
    Dosing / Timing Recommendation DT-01
    55%
    probability of meaningful tolerance improvement
    • 284 similar trajectories
    • 77% showed improvement
    • median effect visible after 5 days

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Mucosal barrier integrity 60
      • DNAFUT2 non-secretor lowers mucosal fucosylation
      • MicrobiomeAkkermansia low → thinner mucus layer
    • Autonomic recovery 25
      • WearableResting HR 81 bpm
    • Inflammatory signalling 20
      • MicrobiomeBacteroides fragilis expansion
    DNA
    Fictional pharmacogenomic panel
    • FUT2 rs601338 AA (non-secretor)
      Reduced mucosal fucosylation
    • CYP2D6 Normal metabolizer
      Expected exposure
    Microbiome
    Shannon diversity 3 · butyrate capacity 52/100
    • Akkermansia muciniphilaLow
    • Faecalibacterium prausnitziiNormal
    • Bacteroides fragilisHigh
    • Bifidobacterium longumLow
    • EnterobacteriaceaeNormal
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    64 ms
    Sleep
    7.1 h
    Steps
    4,540
    Resting HR
    77 bpm
    Daily log: GI score 40, nutritional resilience 55, adherence 85.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
    • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
    • Keep fibre steady; no new sources this week
    • Avoid known triggers for now: fried or oily food, dairy, alcohol
    What to do
    • Track each bowel movement today: time, stool form, urgency, overnight waking
    • A 15-minute walk after lunch
    • Keep the sleep window steady
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the scheduled dose as agreed with your care team
    • Electrolyte solution, one sachet after any loose stool
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0329451%S0432
    P-0309849%S1123
    P-0323148%S1329
    P-0326348%S1836
    P-0308247%S1227
    P-0316246%S0728
    P-0301245%S1113
    P-0313245%S1533
    P-0334745%S0432
    P-0335545%S0231
    P-0340645%S1931
    P-0303944%S1028